Open access
Open access
Powered by Google Translator Translator

RCT: Doxycycline vs. azithromycin for treating anorectal Chlamydia trachomatis infection in women.

11 May, 2022 | 11:15h | UTC

Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial – The Lancet Infectious Diseases (link to abstract – $ for full-text)

Commentary: Doxycycline Bests Azithromycin for Anogenital Chlamydia in Women — Open-label randomized trial set out to duplicate results from prior studies in men – MedPage Today (free registration required)

Related:

Doxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men Who Have Sex With Men: A Randomized Controlled Trial – Clinical Infectious Diseases

Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis – New England Journal of Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.